Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FAPI PET in Pleural Mesothelioma: The Diagnostic Accuracy and Clinical Value of FAPI PET at Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation

NCT06790082 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.

NCT NCT06790082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06790082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FAPI PET in Pleural Mesothelioma: The Diagnostic Accuracy and Clinical Value of FAPI PET at Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation
Lead sponsor
Aalborg University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 29, 2025
Completion date
April 30, 2037
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, fapi, fibroblast activation protein inhibitor, pleural diseases, pleural mesothelioma